Cargando…

Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations

SIMPLE SUMMARY: A substantial disparity in breast cancer incidence and mortality exists between African American (AA) and European American (EA) women. However, the basis for these disparities is poorly understood. In this article, we describe that gene–environment interactions mediated through epig...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Shriya, Garlapati, Chakravarthy, Aneja, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025441/
https://www.ncbi.nlm.nih.gov/pubmed/35454810
http://dx.doi.org/10.3390/cancers14081903
_version_ 1784690872501141504
author Joshi, Shriya
Garlapati, Chakravarthy
Aneja, Ritu
author_facet Joshi, Shriya
Garlapati, Chakravarthy
Aneja, Ritu
author_sort Joshi, Shriya
collection PubMed
description SIMPLE SUMMARY: A substantial disparity in breast cancer incidence and mortality exists between African American (AA) and European American (EA) women. However, the basis for these disparities is poorly understood. In this article, we describe that gene–environment interactions mediated through epigenetic modifications may play a significant role in racial disparities in BC incidence and outcomes. Our in silico analyses and an in-depth literature survey suggest that there exists a significant difference in epigenetic patterns between AA and EA women with breast cancer. Herein, we describe the environmental factors that contribute to these epigenetic changes, which may underlie the disparate racial burden in patients with breast cancer. We suggest that AA women with higher basal epigenetic changes, may have higher pre-disposition to cancer onset, and an aggressive disease course. Pre-existing racial differences in epigenetic profiles of breast tissues raises the possibility of examining these profiles for early diagnosis. ABSTRACT: Breast cancer (BC) is the most commonly diagnosed cancer in women. Despite advancements in BC screening, prevention, and treatment, BC incidence and mortality remain high among African American (AA) women. Compared with European American (EA) women, AA women tend to be diagnosed with more advanced and aggressive tumors and exhibit worse survival outcomes. Most studies investigating the determinants of racial disparities in BC have focused on genetic factors associated with African ancestry. However, various environmental and social stressors over an individual’s life course can also shape racial stratification in BC. These social and environmental exposures result in long-term changes in gene expression mediated by epigenetic mechanisms. Epigenetics is often portrayed as an intersection of socially patterned stress and genetic expression. The enduring nature of epigenetic changes makes them suitable for studying the effects of different environmental exposures over an individual’s life course on gene expression. The role of differential social and environmental exposures in racial disparities in BC suggests varied epigenetic profiles or signatures associated with specific BC subtypes in AA and EA women. These epigenetic profiles in EA and AA women could be used as biomarkers for early BC diagnosis and disease prognosis and may prove valuable for the development of targeted therapies for BC. This review article discusses the current state of knowledge regarding epigenetic differences between AA and EA women with BC. We also discuss the role of socio-environmental factors, including psychosocial stress, environmental toxicants, and dietary factors, in delineating the different epigenetic profiles in AA and EA patients with BC.
format Online
Article
Text
id pubmed-9025441
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90254412022-04-23 Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations Joshi, Shriya Garlapati, Chakravarthy Aneja, Ritu Cancers (Basel) Review SIMPLE SUMMARY: A substantial disparity in breast cancer incidence and mortality exists between African American (AA) and European American (EA) women. However, the basis for these disparities is poorly understood. In this article, we describe that gene–environment interactions mediated through epigenetic modifications may play a significant role in racial disparities in BC incidence and outcomes. Our in silico analyses and an in-depth literature survey suggest that there exists a significant difference in epigenetic patterns between AA and EA women with breast cancer. Herein, we describe the environmental factors that contribute to these epigenetic changes, which may underlie the disparate racial burden in patients with breast cancer. We suggest that AA women with higher basal epigenetic changes, may have higher pre-disposition to cancer onset, and an aggressive disease course. Pre-existing racial differences in epigenetic profiles of breast tissues raises the possibility of examining these profiles for early diagnosis. ABSTRACT: Breast cancer (BC) is the most commonly diagnosed cancer in women. Despite advancements in BC screening, prevention, and treatment, BC incidence and mortality remain high among African American (AA) women. Compared with European American (EA) women, AA women tend to be diagnosed with more advanced and aggressive tumors and exhibit worse survival outcomes. Most studies investigating the determinants of racial disparities in BC have focused on genetic factors associated with African ancestry. However, various environmental and social stressors over an individual’s life course can also shape racial stratification in BC. These social and environmental exposures result in long-term changes in gene expression mediated by epigenetic mechanisms. Epigenetics is often portrayed as an intersection of socially patterned stress and genetic expression. The enduring nature of epigenetic changes makes them suitable for studying the effects of different environmental exposures over an individual’s life course on gene expression. The role of differential social and environmental exposures in racial disparities in BC suggests varied epigenetic profiles or signatures associated with specific BC subtypes in AA and EA women. These epigenetic profiles in EA and AA women could be used as biomarkers for early BC diagnosis and disease prognosis and may prove valuable for the development of targeted therapies for BC. This review article discusses the current state of knowledge regarding epigenetic differences between AA and EA women with BC. We also discuss the role of socio-environmental factors, including psychosocial stress, environmental toxicants, and dietary factors, in delineating the different epigenetic profiles in AA and EA patients with BC. MDPI 2022-04-09 /pmc/articles/PMC9025441/ /pubmed/35454810 http://dx.doi.org/10.3390/cancers14081903 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Joshi, Shriya
Garlapati, Chakravarthy
Aneja, Ritu
Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
title Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
title_full Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
title_fullStr Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
title_full_unstemmed Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
title_short Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
title_sort epigenetic determinants of racial disparity in breast cancer: looking beyond genetic alterations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025441/
https://www.ncbi.nlm.nih.gov/pubmed/35454810
http://dx.doi.org/10.3390/cancers14081903
work_keys_str_mv AT joshishriya epigeneticdeterminantsofracialdisparityinbreastcancerlookingbeyondgeneticalterations
AT garlapatichakravarthy epigeneticdeterminantsofracialdisparityinbreastcancerlookingbeyondgeneticalterations
AT anejaritu epigeneticdeterminantsofracialdisparityinbreastcancerlookingbeyondgeneticalterations